To systematically review the literature to determine safety of cochlear implantation in pediatric patients 12 months and younger.
Data Source
Ovid MEDLINE, EMBASE, CINAHL, and Cochrane Central Register of Controlled Trials (CENTRAL) databases were searched from inception to March 20, 2021.
Review Methods
Studies that involved patients 12 months and younger with report of intraoperative or postoperative complication outcomes were included. Studies selected were reviewed for complications, explants, readmissions, and prolonged hospitalizations. Two independent reviewers screened all studies that were selected for the systematic review and meta-analysis. All studies included were assessed for quality and risk of bias.
Results
The literature search yielded 269 studies, of which 53 studies underwent full-text screening, and 18 studies were selected for the systematic review and meta-analysis. A total of 449 patients and 625 cochlear implants were assessed. Across all included studies, major complications were noted in 3.1% of patients (95% CI, 0.8-7.1) and 2.3% of cochlear implantations (95% CI, 0.6-5.2), whereas minor complications were noted in 2.4% of patients (95% CI, 0.4-6.0) and 1.8% of cochlear implantations (95% CI, 0.4-4.3). There were no anesthetic complications reported across all included studies.
Conclusion
The results of this systematic review and meta-analysis suggest that cochlear implantation in patients 12 months and younger is safe with similar rates of complications to older cohorts.
National Research Council (US) Committee on Disability Determination for Individuals With Hearing Impairments; DobieRAVan HemelS, eds. Hearing Loss: Determining Eligibility for Social Security Benefits. National Academies Press; 2004.
MohrPEFeldmanJJDunbarJL, et al. The societal costs of severe to profound hearing loss in the United States. Int J Technol Assess Health Care. 2000;16(4):1120-1135.
6.
BarkerDHQuittnerALFinkNEEisenbergLSTobeyEANiparkoJK; CDaCI Investigative Team. Predicting behavior problems in deaf and hearing children: the influences of language, attention, and parent-child communication. Dev Psychopathol. 2009;21(2):373-392.
7.
StevensonJMcCannDWatkinPWorsfoldSKennedyC; Hearing Outcomes Study Team. The relationship between language development and behaviour problems in children with hearing loss. J Child Psychol Psychiatry. 2010;51(1):77-83.
8.
VaradarajanVVSydlowskiSALiMMAnneSAdunkaOF. Evolving criteria for adult and pediatric cochlear implantation. Ear Nose Throat J. 2021;100(1):31-37.
9.
HurfordJ. The evolution of the critical period for language acquisition. Cognition. 1991;40:159-201.
10.
Yoshinaga-ItanoCSedeyALCoulterDKMehlAL. Language of early- and later-identified children with hearing loss. Pediatrics. 1998;102(5):1161-1171.
11.
WhiteEJHutkaSAWilliamsLJMorenoS. Learning, neural plasticity, and sensitive periods: implications for language acquisition, musical training, and transfer across the lifespan. Front Syst Neurosci. 2013;7(90):1-18.
12.
CollettiVCarnerMMiorelliVGuidaMCollettiLFiorinoFG. Cochlear implantation at under 12 months: report on 10 patients. Laryngoscope. 2005;115(3):445-449.
13.
DettmanSJPinderDBriggsRJ, et al. Communication development in children who receive the cochlear implant younger than 12 months: risks versus benefits. Ear Hear. 2007;28:12S-18S.
14.
NottPCowanRBrownPMWigglesworthG. Early language development in children with profound hearing loss fitted with a device at a young age: part I—the time period taken to acquire first words and first word combinations. Ear Hear. 2009;30:526-540.
15.
SchauwersKGillisSDaemersKDe BeukelaerCGovaertsP. Cochlear implantation between 5 and 20 months of age: the onset of babbling and the audiologic outcome. Otol Neurotol. 2003;25:263-270.
16.
Fryauf-BertschyHTylerRSKelsayDM, et al. Cochlear implant use by prelingually deafened children: the influences of age at implant and length of device use. J Speech Lang Hear Res. 1997;40:183-189.
17.
NikolopoulosTPArchboldSMO’DonoghueGM. The development of auditory perception in children following cochlear implantation. Int J Pediatr Otorhinolaryngol. 1999;49:S189-S191.
18.
Hay-McCutcheonMJKirkKIHenningSC, et al. Using early language outcomes to predict later language ability in children with cochlear implants. Audiol Neurootol. 2008;13:370-378.
19.
KarltorpEEklöfMÖstlundE, et al. Cochlear implants before nine months of age led to more natural spoken language development without increased surgical risks. Acta Pediatr. 2020;109:332-341.
20.
JohrMHoAWagnerCSLinderT. Ear surgery in infants under one year of age: its risks and implications for cochlear implant surgery. Otol Neurotol. 2008;29(3):310-313.
21.
YoungNM. Infant cochlear implantation and anesthetic risk. Ann Otol Rhinol Laryngol Suppl. 2002;189:49-51.
WoolleyALOserABLuskRPBahadoriRS. Preoperative temporal bone computed tomography scan and its use in evaluating the pediatric cochlear implant candidate. Laryngoscope. 1997;107:1100-1106.
24.
WernerLFayRRPopperA. Human Auditory Development. Springer Science & Business Media; 2011.
25.
JacksonNMGivensVBCarpenterCC, et al. Cochlear trajectory in pediatric patients. Laryngoscope. 2015;125:961-965.
26.
JamesALPapsinBC. Cochlear implant surgery at 12 months of age or younger. Laryngoscope. 2004;114(12):2191-2195.
27.
PageMJMcKenzieJEBossuytPM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2020;372:n71.
28.
WellsGASheaBO’ConnellDPJWelchVLososMTP. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. The Ottawa Hospital Research Institute; 2014.
29.
HigginsJPThompsonSG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
30.
R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2021.
31.
AnagiotosABeutnerD. The impact of blood loss during cochlear implantation in very young children. Eur Arch Otorhinolaryngol. 2013;270(9):2439-2444.
32.
Lesinski-SchiedatAIllgAHeermannRBertramBLenarzT. Paediatric cochlear implantation in the first and in the second year of life: a comparative study. Cochlear Implants Int. 2004;5(4):146-159.
33.
MiyamotoRTColsonBHenningSPisoniD. Cochlear implantation in infants below 12 months of age. World J Otorhinolaryngol Head Neck Surg. 2018;3(4):214-218.
34.
MiyamotoRTHoustonDMBergesonT. Cochlear implantation in deaf infants. Laryngoscope. 2005;115(8):1376-1380.
35.
O’ConnellBPHolcombMAMorrisonDMeyerTAWhiteDR. Safety of cochlear implantation before 12 months of age: Medical University of South Carolina and Pediatric American College of Surgeons–National Surgical Quality improvement program outcomes. Laryngoscope. 2016;126(3):707-712.
36.
RolandJTJrCosettiMWangKHImmermanSWaltzmanSB. Cochlear implantation in the very young child: long-term safety and efficacy. Laryngoscope. 2009;119(11):2205-2210.
37.
RoukemaBYVan LoonMCSmitsC, et al. Cochlear implantation after bacterial meningitis in infants younger than 9 months. Int J Otolaryngol. 2011;2011:1-9.
38.
ValenciaDMRimellFLFriedmanBJOblanderMRHelmbrechtJ. Cochlear implantation in infants less than 12 months of age. Int J Pediatr Otorhinolaryngol. 2008;72(6):767-773.
39.
WaltzmanSBRolandJTJr.Cochlear implantation in children younger than 12 months. Pediatrics. 2005;116(4):e487-e493.
40.
BirmanC. Cochlear implant surgical issues in the very young child. Cochlear Implants Int. 2009;10(suppl 1):19-22.
41.
HoffSRyanMThomasD, et al. Safety and effectiveness of cochlear implantation of young children, including those with complicating conditions. Otol Neurotol. 2019;40(4):454-463.
42.
HolmanMACarlsonMLDriscollCL, et al. Cochlear implantation in children 12 months of age and younger. Otol Neurotol. 2013;34(2):251-258.
43.
CohenMSHaAYKitskoDJChiDH. Surgical outcomes with subperiosteal pocket technique for cochlear implantation in very young children. Int J Pediatr Otorhinolaryngol. 2014;78(9):1545-1547.
44.
YangYChenMZhengJ, et al. Clinical evaluation of cochlear implantation in children younger than 12 months of age. Pediatr Investig. 2020;4(2):99-103.
45.
ChweyaCMSmithAJMayMM, et al. Prevalence of surgical, anesthetic, and device-related complications among infants implanted before 9 and 12 months of age versus older children: evidence for the continued expansion of pediatric cochlear implant candidacy criteria. Otol Neurotol. 2021;42(6):e666-e674.
46.
HalawaniRAldhafeeriAAlajlanSAlzhraniF. Complications of post-cochlear implantation in 1027 adults and children. Ann Saudi Med. 2019;39:77-81.
47.
PetersenHWalshePGlynnF, et al. Occurrence of major complications after cochlear implant surgery in Ireland. Cochlear Implants Int. 2018;19:297-306.
48.
TheunisseHJPenningsRJEKunstHPMMulderJJMylanusEAM. Risk factors for complications in cochlear implant surgery. Eur Arch Otorhinolaryngol. 2018;275:895-903.
49.
JiangYGuPLiB, et al. Analysis and management of complications in a cohort of 1,065 minimally invasive cochlear implantations. Otol Neurotol. 2017;38:347-351.
BlackB. Keyhole cochlear implantation: current status. Otol Neurotol. 2011;32:1459-1463.
52.
HansenSAnthonsenKStangerupSEJensenJHThomsenJCaye-ThomasenP. Unexpected findings and surgical complications in 505 consecutive cochlear implantations: a proposal for reporting consensus. Acta Otolaryngol. 2010;130:540-549.
53.
DingXTianHWangWZhangD. Cochlear implantation in China: review of 1,237 cases with an emphasis on complications. ORL J Otorhinolaryngol Relat Spec. 2009;71:192-195.
54.
VenailFSicardMPironJP, et al. Reliability and complications of 500 consecutive cochlear implantations. Arch Otolaryngol Head Neck Surg. 2008;134:1276-1281.
55.
KimCSOhSHChangSOKimHMHurDG. Management of complications in cochlear implantation. Acta Otolaryngol. 2008;128:408-414.
56.
CarlsonML. Cochlear implantation in adults. N Engl J Med. 2020;382:1531-1542.
57.
BenchetritLJabbourNAppachiSLiuYCCohenMSAnneS. Cochlear implantation in pediatric patients with enlarged vestibular aqueduct: a systematic review [published online July 7, 2021]. Laryngoscope.
58.
HashemiSBBozorgiHKazemiTBabaeiA. Cerebrospinal fluid gusher in cochlear implant and its associated factors. Acta Otolaryngol. 2020;140(8):621-625.
59.
JethanamestDChannerGAMossWJLustigLRTelischiFF. Cochlear implant fixation using a subperiosteal tight pocket without either suture or bone-recess technique. Laryngoscope. 2014;124(7):1674-1677.
60.
SweeneyADCarlsonMLValenzuelaCV, et al. 228 cases of cochlear implant receiver-stimulator placement in a tight subperiosteal pocket without fixation. Otolaryngol Head Neck Surg. 2015;152(4):712-717.
61.
ReefhuisJHoneinMAWhitneyCG, et al. Risk of bacterial meningitis in children with cochlear implants. N Engl J Med. 2003;349:435-445.
62.
CohenNLHirschBE. Current status of bacterial meningitis after cochlear implantation. Otol Neurotol. 2010;31(8):1325-1328.
63.
TandonSSinghSSharmaSLahiriAK. Use of intrathecal fluorescein in recurrent meningitis after cochlear implantation. Iran J Otorhinolaryngol. 2016;28(86):221-226.
64.
PageELEbyTL. Meningitis after cochlear implantation in Mondini malformation. Otolaryngol Head Neck Surg. 1997;116(1):104-106.
65.
KimitsukiTInamitsuMKomuneSKomiyamaS. Congenital malformation of the inner ear associated with recurrent meningitis. Eur Arch Otorhinolaryngol. 1999;256(suppl 1):S11-S14.
66.
LalwaniAKCohenNL. Does meningitis after cochlear implantation remain a concern in 2011?Otol Neurotol. 2012;33(1):93-95.
67.
KahueCNSweeneyADCarlsonMLHaynesDS. Vaccination recommendations and risk of meningitis following cochlear implantation. Curr Opin Otolaryngol Head Neck Surg. 2014;22(5):359-366.
BiernathKRReefhuisJWhitneyCGMannEACostaPEichwaldJBoyleC. Bacterial meningitis among children with cochlear implants beyond 24 months after implantation. Pediatrics. 2006;117(2):284-289.
70.
ReefhuisJHoneinMAWhitneyCG, et al. Risk of bacterial meningitis in children with cochlear implants. N Engl J Med. 2003;349(5):435-445.
71.
JöhrMHoAWagnerCSLinderT. Ear surgery in infants under one year of age: its risks and implications for cochlear implant surgery. Otol Neurotol. 2008;29(3):310-313.
72.
LiuXJiJZhaoGQ. General anesthesia affecting on developing brain: evidence from animal to clinical research. J Anesth. 2020;34(5):765-772.
73.
McCannMEde GraaffJCDorrisL, et al; GAS Consortium. Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial. Lancet. 2019;393(10172):664-677.
74.
US Food and Drug Administration. FDA Drug Safety Communication: FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women. 2016. Accessed January 9, 2021. http://www.fda.gov/Drugs/DrugSafety/ucm532356.htm
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
